NCT03326765

Brief Summary

The proposed research project is aimed at further characterization of sleep problems and evaluation of their impact in children and adults with TSC, excluding epilepsy as contributing factor. Questionnaire-based studies have shown that sleep problems occur in up to half of the children and a third of adults with tuberous sclerosis complex (TSC). However, there is only limited information on the nature of sleep problems and their impact on patients with TSC and their families.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 27, 2017

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

October 6, 2017

Completed
25 days until next milestone

First Posted

Study publicly available on registry

October 31, 2017

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2019

Completed
Last Updated

October 17, 2018

Status Verified

October 1, 2018

Enrollment Period

2.1 years

First QC Date

October 6, 2017

Last Update Submit

October 15, 2018

Conditions

Keywords

tuberous sclerosis complex (TSC)ChildrenAdults

Outcome Measures

Primary Outcomes (1)

  • characterize the sleep phenotype of TSC in children and adults without epilepsy

    \- Sleep efficiency (SE%): the percentage ratio between total sleep time and time in bed (TST/TIB\*100)

    1 night

Study Arms (2)

Children

OTHER

Questionnaires electroencephalogram (EEG) Actigraphy polysomnography

Other: QuestionnairesProcedure: electroencephalogram (EEG)Procedure: polysomnographyProcedure: Actigraphy

Adults

OTHER

Questionnaires electroencephalogram (EEG) Actigraphy polysomnography

Other: QuestionnairesProcedure: electroencephalogram (EEG)Procedure: polysomnographyProcedure: Actigraphy

Interventions

* Epworth sleepiness scale * Pittsburgh sleep quality Index (PSQI) * EQ-5D Adults * Pediatric Daytime Sleepiness scale (PDSS) * Sleep disturbance Scale for Children (SDSC * EQ-5D Children * Sleaping diary

AdultsChildren

is an electrophysiological monitoring method to record electrical activity of the brain

AdultsChildren

type of sleep study, is a multi-parametric test used in the study of sleep and as a diagnostic tool in sleep medicine

AdultsChildren
ActigraphyPROCEDURE

type of sleep study based on bracelet around the wrist

AdultsChildren

Eligibility Criteria

Age1 Day - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Children and adults with definite TSC based on the 2012 Consensus Conference Diagnostic

You may not qualify if:

  • daily alcohol intake
  • pregnancy
  • caffeine abuse (\>4 cups/day)
  • shift work
  • drug abuse
  • anti-depressive therapy
  • medications as benzodiazepine, melatonin, phenobarbital and antihistamines
  • the presence of clinical or electrographic seizures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitair Ziekenhuis Brussel

Jette, Vlaams Brabant, 1090, Belgium

RECRUITING

MeSH Terms

Conditions

Sleep Wake DisordersTuberous Sclerosis

Interventions

Surveys and QuestionnairesActigraphy

Condition Hierarchy (Ancestors)

Nervous System DiseasesNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersHamartomaNeoplasmsNeoplasms, Multiple PrimaryNeoplastic Syndromes, HereditaryMalformations of Cortical Development, Group IMalformations of Cortical DevelopmentNervous System MalformationsNeurocutaneous SyndromesHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGenetic Diseases, Inborn

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthMonitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosisAccelerometry

Study Officials

  • Anna Jansen, PhD, MD

    Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR
  • Sonia De Weerdt, MD

    Universitair Ziekenhuis Brussel

    PRINCIPAL INVESTIGATOR
  • Alessandra Pereira,, PhD, MD

    Department of Pediatrics School of Medicine, PUCRS, Brazil

    PRINCIPAL INVESTIGATOR
  • Magda Nunes, PhD, MD

    Director, School of Medicine, PUCRS, Brazil; Brain Instititute of Rio Grande do Sul, Brazil

    PRINCIPAL INVESTIGATOR
  • Oliviero Bruni, PhD, MD

    Department of Developmental and Social Psychology, Sapienza University of Rome, Italy

    PRINCIPAL INVESTIGATOR
  • Paolo Curatolo, PhD, MD

    Director, Child Neurology and Psychiatry Unit, Systems Medicine Department, Tor Vergata University of Rome, Italy

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Veerle Van Mossevelde, Study coordinator

CONTACT

Dirk De Clippeleir, Study coordinator

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: 2 groups: * 30 Children(0-18y) withTSC without epilepsy * 30 Adults(\>18y) withTSC without epilepsy
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study coordinator

Study Record Dates

First Submitted

October 6, 2017

First Posted

October 31, 2017

Study Start

September 27, 2017

Primary Completion

November 1, 2019

Study Completion

November 30, 2019

Last Updated

October 17, 2018

Record last verified: 2018-10

Locations